A quick and inexpensive method for immediate pontic fabrication.

N. Kravitz,B. Kusnoto

2006-12-01

Abstract:

What problem does this paper attempt to address?

Hematogenous dissemination of Hodgkin's disease.

A. Aisenberg

DOI: https://doi.org/10.7326/0003-4819-77-5-810

IF: 39.2

Annals of Internal Medicine

Abstract:
Causes of Death in Hospitalized Patients with Systemic Lupus Erythematosus: a 10-Year Multicenter Nationwide Chinese Cohort

Xin-yao Wu,Min Yang,Yue-sheng Xie,Wei-guo Xiao,Jin Lin,Bin Zhou,Xin Guan,Cai-nan Luo,Nan Che,Xing-zhen Liu,Chao Wang,Jia-lin Teng,Xiao-bing Cheng,Jun-na Ye,Yu-tong Su,Hui Shi,Yu-feng Yin,Meng-ru Liu,Yue Sun,Qiong-Yi Hu,Zhuo-chao Zhou,Hui-hui Chi,Yi Liu,Xiao Zhang,Jin-wei Chen,Miao-jia Zhang,Dong-bao Zhao,Cheng-de Yang,Li-jun Wu,Hong-lei Liu

DOI: https://doi.org/10.1007/s10067-018-4259-z

2018-01-01

Clinical Rheumatology

Abstract:To estimate the mortality and describe the causes of death in a large multicenter cohort of hospitalized patients with SLE in China. This was a retrospective study of a nationwide SLE cohort (10 centers, 29,510 hospitalized patients) from 2005 to 2014 in China. Standardized mortality ratios (SMRs) were calculated for all death and were stratified by sex and age. Chi-square test was used to determine whether the major causes of death vary in age, sex, duration of SLE, disease activity, or medications. Comparison between dead patients and survival controls was used to identify the risk factors for mortality. Logistic regression analysis was used to evaluate the risk factors for mortality. A total of 360 patients died during the study period, accounting for 1.22%. The overall SMR was 2.13 (95% CI 1.96, 2.30), with a particularly high SMR seen in subgroups characterized by younger age. Infection (65.8%) was the most common cause of death, followed by lupus nephritis (48.6%), hematological abnormality (18.1%), neuropsychiatric lupus/NPSLE (15.8%), and interstitial pneumonia (13.1%). Cardiovascular disease and malignancy contributed little to the causes of death. Infection, in particular severe pulmonary infection, emerged as the foremost risk factor for mortality, followed by lupus encephalopathy. However, lupus nephritis and hematological abnormalities occurred more frequently in survival patients. SLE patients at a younger age of diagnosis have a poorer prognosis. Infection dominated the causes of death in recent China. Ethnicity and medications might account for the differences in causes of death compared with western populations.
Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China

Chan-Yuan Wu,Cai-Feng Li,Qing-Jun Wu,Jian-Hua Xu,Lin-Di Jiang,Lu Gong,Feng-Qi Wu,Jie-Ruo Gu,Jiu-Liang Zhao,Meng-Tao Li,Yan Zhao,Xiao-Feng Zeng,CSTAR Co-authors

DOI: https://doi.org/10.4103/0366-6999.206346

2017-06-05

Abstract:Background: Approximately 15-20% cases of systemic lupus erythematosus (SLE) are diagnosed in children. There have been a few studies reporting the epidemiological data of pediatric-onset SLE (cSLE) in China, neither comparing the differences between cSLE and adult-onset SLE (aSLE). The aim of this study was to describe the impact of age of onset on clinical features and survival in cSLE patients in China based on the Chinese SLE Treatment and Research group (CSTAR) database. Methods: We made a prospective study of 225 cSLE patients (aged Results: The mean age of cSLE patients was 12.16 ± 2.92 years, with 187 (83.1%) females. Fever (P < 0.001) as well as mucocutaneous (P < 0.001) and renal (P = 0.006) disorders were found to be significantly more frequent in cSLE patients as initial symptoms, while muscle and joint lesions were significantly less common compared to aSLE subjects (P < 0.001). The cSLE patients were found to present more frequently with malar rash (P = 0.001; odds ratio [OR], 0.624; 95% confidence interval [CI], 0.470-0.829) but less frequently with arthritis (P < 0.001; OR, 2.013; 95% CI, 1.512-2.679) and serositis (P = 0.030; OR, 1.629; 95% CI, 1.053-2.520). There was no significant difference in SLE disease activity index scores between cSLE and aSLE groups (P = 0.478). Cox regression indicated that childhood onset was the risk factor for organ damage in lupus patients (hazard ratio 0.335 [0.170-0.658], P = 0.001). The survival curves between the cSLE and aSLE groups had no significant difference as determined by the log-rank test (0.557, P = 0.455). Conclusions: cSLE in China has different clinical features and more inflammation than aSLE patients. Damage may be less in children and there is no difference in 5- year survival between cSLE and aSLE groups.
A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum

Hui Jin,Tao Huang,Ruifang Wu,Ming Zhao,Haijing Wu,Hai Long,Heng Yin,Jieyue Liao,Shuangyan Luo,Yu Liu,Qing Zhang,Peng Zhang,Yixin Tan,Shuaihantian Luo,Xin Huang,Yaxiong Deng,Wei Liao,Liu Duan,Jianbo Chen,Yin Zhou,Jinghua Yin,Hong Qiu,Jin Yuan,Zijun Wang,Mengying Li,Xiaoqi Wu,Lina Chen,Liangmin Cai,Cancan Huang,Qianwen Li,Bingsi Tang,Bihui Yu,Xin Li,Xiaofei Gao,Yixi Hu,Xiaolei Ren,Haofan Xue,Zhangming Wei,Jinwei Chen,Fen Li,Guanghui Ling,Hui Luo,Hongjun Zhao,Sen Yang,Yong Cui,Youkun Lin,Xu Yao,Lingyun Sun,Qing Guo,Hong Fang,Kang Zeng,Danqi Deng,Jianzhong Zhang,Yuzhen Li,Xiongming Pu,Xiangping Liao,Xiqiang Dang,Danlin Huang,Yumei Liang,Qing Sun,Hongju Xie,Li Zeng,Cibo Huang,Qingchun Diao,Juan Tao,Jianbin Yu,Zhenlu Li,Hanshi Xu,Hui Li,Wei Lai,Xiguang Liu,Jingjing Wu,Tienan Li,Tiechi Lei,Qiuning Sun,Yanjia Li,Guoqiang Zhang,Xin Huang,Qianjin Lu

DOI: https://doi.org/10.1177/0961203320959716

IF: 2.858

2020-01-01

Lupus

Abstract:Although the original purpose of the systemic lupus erythematosus (SLE) classification criteria was to distinguish SLE from other mimic diseases, and to facilitate sample selection in scientific research, they have become widely used as diagnostic criteria in clinical situations. It is not known yet if regarding classification criteria as diagnostic criteria, what problems might be encountered? This is the first study comparing the three sets of classification criteria for SLE, the 1997 American College of Rheumatology (ACR'97), 2012 Systemic Lupus International Collaborating Clinics (SLICC'12) and 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR'19), for their ability to distinguish patients with SLE from patients with pure mucocutaneous manifestations (isolated cutaneous lupus erythematosus without internal disease, i-CLE) in the lupus disease spectrum. 1,865 patients with SLE and 232 patients with i-CLE were recruited from a multicenter study. We found that, due to low specificity, none of the three criteria are adept at distinguishing patients with SLE from patients with i-CLE. SLICC'12 performed best among the original three criteria, but if a positive ANA was removed as an entry criterion, EULAR/ACR'19 would performed better. A review of previous studies that compared the three sets of criteria was presented in this work.
Differences In Clinical Features And Laboratory Results Between Adults And Children With Sars-Cov-2 Infection

Xiaoli Li,Yan Rong,Peiyan Zhang,Junli Wang,Liping Qie,Lei Rong,Jian Xu

DOI: https://doi.org/10.1155/2020/6342598

2020-01-01

BioMed Research International

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children accounts for a small proportion of all infections and is usually mild or asymptomatic. There are few studies on the clinical characteristics of SARS-CoV-2 infection in children, and the causes of the low prevalence in children remain unclear. Herein, we compared the epidemiological and clinical characteristics of SARS-CoV-2 infection between adults and children. Fifty-two patients with Coronavirus Disease 2019 (COVID-19) were retrospectively analyzed, including 38 adults and 14 children. Their clinical information such as epidemiological exposure history, laboratory indicators, chest computed tomography (CT) performance, and number of SARS-CoV-2 positive days were analyzed and compared. In children, 5 (35.71%) had mild COVID-19 and 9 (64.29%) had common type, while, in adults, 9 (23.68%) cases were mild, and 29 (76.32%) were common COVID-19. Among them, family clustering infection accounted for 50% (7/14) of child cases and 23.68% (9/36) of adult cases. Epidemiological exposure history, clinical classification, clinical symptoms, chest CT manifestations, and number of SARS-CoV-2-positive days were not significantly different between children and adults. However, the percentage of neutrophils in adults was significantly higher than that in children (P<0.05). The percentage and absolute value of lymphocytes, platelet counts, aspartate aminotransferase, and aspartate aminotransferase/alanine aminotransferase in adults were lower than those in children (P<0.05). Conclusively, children infected with SARS-CoV-2 show the characteristics of family clustering, and the proportion of mild and asymptomatic infections is higher. For families with a history of epidemiological exposure, routine SARS-CoV-2 nucleic acid testing and chest CT examination should be performed in asymptomatic children to determine whether they are infected. Unlike adults, although the reduction of lymphocytes and platelets in children is not common, it is necessary to be alert to the increased risk of liver damage in children.
Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients

Maria Fernanda Ferraz Bortolini,Vitória Peres Pereira,Thiago Af Gomes Dos Santos,Renato Nisihara,Thelma L Skare

DOI: https://doi.org/10.1177/09612033211010330

IF: 2.858

Lupus

Abstract:Background: Systemic lupus erythematosus (SLE) may have a different serological and clinical profile according to age of disease onset. Aim: To compare clinical presentation and serological data from patients with SLE onset in childhood (cSLE) with disease onset in adulthood (aSLE) in a sample of Brazilian patients. Methods: Retrospective study of 614 SLE patients from a single Rheumatology Unit from Brazil: 77 (12.5%) cSLE and 537 (87.4%) aSLE. Clinical and serological data were obtained from the charts. Comparisons of cSLE with aSLE in general and according to patient's gender were made. Results: The comparison of whole sample showed that children had more malar rash (p = 0.04), seizures (p < 0.0001), psychosis (p = 0.02), glomerulonephritis (p = 0.001), anti-dsDNA (p = 0.008), anticardiolipin IgM (p = 0.04) but less discoid lesions (p = 0.01), anti-Ro (p < 0.0001) and anti-La antibodies (p = 0.007). When only the male sample was compared, no differences in glomerulonephritis and anti-dsDNA frequencies were found. Conclusion: Children had a higher frequency of severe manifestations (glomerulonephritis and central nervous system) than adults. The difference in glomerulonephritis occurrence disappeared when only males were compared.
Re: "Those who were wrong".

S. Greenland

DOI: https://doi.org/10.1093/OXFORDJOURNALS.AJE.A115697

1990-09-01

American Journal of Epidemiology

Abstract:
A clinical analysis of male and female patients with systemic lupus erythematosus in child-bearing age

袁风红,孙凌云,邹耀红,潘文友,王向党,潘解萍,张缪佳,张育,谭魁麟

DOI: https://doi.org/10.3760/cma.j.issn.1007-7480.2014.12.010

2014-01-01

Abstract:Objective To analyze the clinical characteristics of male and female patients with systemic lupus erythematosus (SLE) in child-bearing age.Methods Data was collected by the same methods in the past ten years in fifteen hospitals in Jiangsu Province and then it was summarized for retrospective analysis.The difference in clinical manifestations,laboratory features and outcome were analyzed between male and female patients and then the data was analyzed by chi-square test and Wilcoxon rank sum test.Results One thousand eight hundred and thirty nine SLE patients (117 male and 1 722 female patients) were investigated.In the case control study,male patients had an older onset age [(32±12) years old] and hospitalized age [(36±12) years old] than female patients [(30±10) and (33±10) years old] (x2=-2.151,x2 =-2.171,P ＜0.05).Male patients had more serositis,general lymphadenopathy/hepatosplenomegaly and fatality rate [male:13.68％(16/117),female:7.38％(127/1 722),x2=6.064,P＜0.05] while female patients had more arthritis and anemia (P＜0.05).Male patients had higher frequency of liver function abnormalities and higher serum creatinine (Scr) while female patients had higher anti-dsDNA positivity rate (P＜0.05).Among the 135 deceased patients,severe infection was the main cause of death in male and female patients,followed by kidney damage in female patients and nervous system damage in male patients.Conclusion Our study suggests that there are major clinical differences between male and female patients with SLE in child bearing age.Male patients have much more severe organ damage than female patients and male patients has higher rate of fatality rate and worse prognostic than female patients.
Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study

Sihao Gao,Zhongxun Yu,Xudong Ma,Jialu Sun,Aiguo Ren,Sifa Gao,Mengchun Gong,Xiang Zhou,Mingsheng Ma,Hongmei Song

DOI: https://doi.org/10.1016/S2352-4642(24)00172-X

Abstract:Background: Childhood-onset systemic lupus erythematosus (SLE) is a complex autoimmune disorder that can lead to serious organ damage. Despite the prevalence of SLE among children in Asian countries, treatment guidelines, prognosis, and clinical decision making for children with SLE are limited by gaps in region-specific epidemiological data. The aim of this study was to analyse epidemiological characteristics of childhood-onset SLE and associated organ involvement and in-hospital mortality in China. Methods: In this nationwide study, we searched standardised hospital discharge records submitted to the Hospital Quality Monitoring System (HQMS) between Jan 1, 2016, and Dec 31, 2021, for patients with a diagnosis of childhood-onset SLE based on the 2019 American College of Rheumatology or 2012 Systemic Lupus International Collaborating Clinics classification criteria. We selected records for patients aged 18 years and younger containing relevant ICD 10th revision diagnostic codes (specifically M32) among discharge diagnostic codes. We excluded records for patients younger than 5 years, whose SLE diagnosis was presumed to be monogenic lupus, and for patients with overlap syndromes or unidentified sex. Date of diagnosis (equal to the first hospital discharge date), age, organ involvement, intensive care unit (ICU) treatment, and in-hospital mortality were extracted from the records. Incidence rates for 2017, 2018, 2019, 2020, and 2021 were identified with five washout periods ranging from 12 months (Jan 1-Dec 31, 2016) to 60 months (Jan 1, 2016-Dec 31, 2020). Data were stratified by sex, age relative to puberty onset, organ involvement and concurrent infection at time of diagnosis, human development index of region of residence, hospital level, and hospital type. Incidence trends by sex, age relative to puberty onset, and year were derived by joinpoint regression analysis, with 95% CIs calculated by the Poisson exact method. Major organ involvement was assessed according to definitions in the British Isles Lupus Assessment Group 2004 disease activity index. Outcomes of ICU admission after first diagnosis and in-hospital death after ICU admission were analysed in Cox proportional hazards models, with p values and 95% CIs calculated with the parametric method. Findings: Between Jan 1, 2016, and Dec 31, 2021, the HQMS received 134 956 hospital discharge records containing the M32 discharge diagnostic code for patients aged 18 years or younger. 6286 records were excluded, leaving 128 670 records representing 54 338 patients aged 5-18 years; of these, 43 756 patients (36 153 girls and 7603 boys) received their childhood-onset SLE diagnosis on or after Jan 1, 2017. Between Jan 1, 2017, and Dec 31, 2021, the SLE incidence rate was 3·97 (95% CI 3·93-4·01) per 100 000 person-years, with a declining trend during the 5-year period. Joinpoint analysis showed sex-dependent and age-dependent incidence patterns. After a relatively stable incidence rate among prepubertal children aged 5-7 years, the incidence rate increased among peripubertal children aged 8-12 years by 0·92 cases per 100 000 person-years with each 1-year increase in age (p<0·0001). Among peripubertal children aged 8-12 years, girls showed the largest change in incidence rate, with an increase of 1·64 per 100 000 person-years with each 1-year increase in age (p<0·0001), compared with 0·40 per 100 000 person-years with each 1-year increase in age among boys (p=0·013). The organ systems most affected in patients with childhood-onset SLE were the kidneys (56·8%) and the haematological system (27·8%). Among the 2471 patients admitted to the ICU, 213 (9%) of whom died in ICU, the three organ-related risk factors at initial diagnosis that showed greatest association with progression to critical illness were cardiovascular involvement (adjusted hazard ratio 2·50 [95% CI 2·18-2·87]; p<0·0001), neuropsychiatric SLE (2·10 [1·87-2·37]; p<0·0001), and serositis (2·03 [1·78-2·30]; p<0·0001). Other prominent risk factors for progression to critical illness were concurrent infections with Epstein-Barr virus (1·52 [1·16-1·98]; p=0·0020) or fungi (1·49 [1·22-1·83]; p=0·0001). In total, 396 (0·7%) of 54 338 patients with childhood-onset SLE died in hospital; the most common causes of death were pneumonia (146 [37%]), multi-organ dysfunction syndrome (99 [25%]), and renal failure (75 [19%]). Risk of in-hospital mortality was highest among pubertal children (hazard ratio 2·16 [95% 1·14-4·09]) compared with prepubertal children, and risk of ICU admission was highest among prepubertal children (2·95 [2·16-4·03]) compared with postpubertal children. Interpretation: These nationwide data on the epidemiology of childhood-onset SLE in the Chinese paediatric population show for the first time a declining trend in incidence rates, rapid rise in puberty-onset rates, and the distinct involvement of vital organs from disease onset to mortality in China. They underscore the complexity of childhood-onset SLE pathogenesis and emphasise the imperative for stratified precision treatment, informed interventions, and health-care planning for childhood-onset SLE. Funding: National Key Research & Development Program of China.
A comparative study between the disease characteristics in adult-onset and childhood-onset systemic lupus erythematosus in Egyptian patients attending a large university hospital

Kamal El-Garf,Ayman El-Garf,Rasha Gheith,Shaimaa Badran,Samia Salah,Huda Marzouk,Yomna Farag,Iman Khalifa,Noha Mostafa

DOI: https://doi.org/10.1177/0961203320972778

IF: 2.858

Lupus

Abstract:Introduction: Disease features and laboratory abnormalities differ among adult-onset and childhood-onset systemic lupus erythematosus (aSLE and cSLE). Socioeconomic status both independent of, and in combination with, ethnicity influences the disease phenotype and outcome. Objective: To compare the various disease features among patients with cSLE and aSLE in a limited monetary income Egyptian cohort attending a large free-of-charge university hospital. Patients and methods: Retrospective analysis of the medical records of 714 SLE patients attending Cairo University Hospitals from January 2000 to December 2019. Of them 602 (400 with aSLE and 202 with cSLE) were enrolled in the study. Results: The mean age of disease onset was 28.27 ± 10.55 among aSLE patients compared to 12.88 ± 4.26 years among cSLE patients. Disease duration was 12.03 ± 5.05 and 4.14 ± 3.18 years in aSLE and cSLE, respectively. Female to male ratio was 15:1 among patients with aSLE, as compared to 2.67:1 among cSLE (<0.001). Arthritis (69%), oral ulcers (48.5%), neuropsychiatric (18.3%) and thrombotic manifestations of antiphospholipid syndrome (12%) were significantly more frequent in aSLE. On the other hand, renal (67.8%), serositis (49.6%), fever (49%), lymphopenia (40.6%), hemolytic anemia (38.6%), and discoid lupus (13.4%) were significantly more frequent in cSLE. Weight loss, malar rash, photosensitivity, thrombocytopenia, leucopenia and lymphadenopathy were not significantly different between the two groups. Hypocomplementemia, proteinuria, urinary sediments, hematuria were significantly more frequent in cSLE. For those patients with renal involvement, who underwent renal biopsy (58.3% in aSLE and 63.5% in cSLE), there was no significant difference with regard to the different histopathological classes. Anti-Smith, anti-cardiolipin antibodies and rheumatoid factor were significantly more frequent among aSLE patients, while anti-La antibodies were more frequent among cSLE patients. Conclusion: Arthritis was the most common clinical manifestation over time in aSLE compared to renal involvement in cSLE. Renal disease tends to be more active in cSLE. The differences in disease manifestations between this cohort and other studies can be attributed to the ethnic and socioeconomic disparities.
Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study

Lihui Wen,Ziyan Chen,Ziyi Jin,Wenyou Pan,Lin Liu,Min Wu,Fuwan Ding,Huaixia Hu,Xiang Ding,Hua Wei,Yaohong Zou,Xian Qian,Meimei Wang,Jian Wu,Juan Tao,Jun Tan,Zhanyun Da,Miaojia Zhang,Jing Li,Xuebing Feng,Jun Liang,Huayong Zhang,Lingyun Sun

DOI: https://doi.org/10.1038/s41598-022-14840-4

IF: 4.6

2022-06-25

Scientific Reports

Abstract:Studies on clinical features of systemic lupus erythematosus among different age-onset patients are lacking in China. This multicentre study aimed to systemically compare clinical manifestations, comorbidities, organ involvement, and laboratory findings among 797 Chinese juvenile-onset, adult-onset, and late-onset SLE (JSLE, ASLE, and LSLE) patients. They were classified into JSLE, ASLE, and LSLE groups if first diagnosed at 50 years old, respectively. Chi-square test and analysis of variance were employed for categorical and continuous variables respectively. In younger-onset patients, the SLE Disease Activity Index 2000 score was significantly higher (JSLE vs. ASLE vs. LSLE = 17.43 ± 9.139 vs. 16.34 ± 8.163 vs. 14.08 ± 6.474, p = 0.031). Mucocutaneous symptoms (79.5% vs. 73.4% vs. 62.0%, p = 0.042), especially malar rash (76.1% vs. 66.1% vs. 53.5%, p = 0.011) occurred more frequently, and proteinuria rate was higher (54.5% vs. 56.3% vs. 36.6%, p = 0.007). In later-onset patients, cardiopulmonary involvement increased (11.4% vs. 24.3% vs. 29.6%, p = 0.012). In ASLE, hypoalbuminemia rate elevated (46.6% vs. 59.9% vs. 47.9%, p = 0.015). Our study demonstrated in a Chinese population that JSLE may be more active and suffer mucocutaneous disorders, while LSLE tended to suffer cardiopulmonary involvement at-onset. These findings may help identify treatment priorities when facing different age-onset SLE patients.

multidisciplinary sciences
Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey

Bahar Artim-Esen,Sezgin Şahin,Erhan Çene,Yasemin Şahinkaya,Kenan Barut,Amra Adrovic,Yasemin Özlük,Işın Kılıçaslan,Ahmet Omma,Ahmet Gül,Lale Öcal,Özgür Kasapçopur,Murat İnanç

DOI: https://doi.org/10.3899/jrheum.160340

Abstract:Objective: Age at onset has been shown to affect the clinical course and outcome of systemic lupus erythematosus (SLE). Herein, we aimed to define the differences in clinical characteristics, organ damage, and survival between patients with juvenile-onset (jSLE) and adult-onset SLE (aSLE). Methods: For the study, 719 patients (76.9%) with aSLE and 216 (23.1%) with jSLE were examined. Comparisons between the groups were made for demographic characteristics, clinical features, auto-antibody profiles, damage, and survival rates. Results: These results were significantly more frequent in jSLE: photosensitivity, malar rash, oral ulcers, renal involvement, neuropsychiatric (NP) manifestations, and autoimmune hemolytic anemia (AIHA). Of the autoantibodies, a higher frequency of anti-dsDNA and anticardiolipin IgG and IgM were observed in the jSLE group. A significant proportion of patients with aSLE had anti-Sm positivity and pleuritis. The proportion of patients with jSLE who developed organ damage was comparable to that of patients with aSLE (53% vs 47%) and the mean damage scores were similar in both groups. Renal damage was significantly more frequent in jSLE while musculoskeletal and cardiovascular system damage and diabetes mellitus were more prominent in aSLE. Comparison of survival rates of the 2 groups did not reveal any significant differences. Conclusion: We report a higher frequency in the jSLE group of renal involvement, cutaneous symptoms, oral ulcers, NP manifestations, AIHA, and anti-dsDNA positivity. A significant proportion of patients in the jSLE group had damage, most prominently in the renal domain. Our findings might support different genetic/environmental backgrounds for these 2 subgroups.
A Distributed Generation Control Architecture for Small-Footprint Power Systems

S. T. Cady,A. Domínguez-García,C. Hadjicostis

2013-07-01

Abstract:In this paper, we propose a distributed architecture for generation control in small-footprint power systems. Although they are smaller and have lower ratings, the generation control objectives for a small-footprint power system are similar to those in larger counterparts, e.g., bulk-power transmission networks. However, in large power systems, the implementation of the generation control functions is centralized, i.e., there is a computer that resides in a centralized location, e.g., a control center, with measurements and control signals telemetered to and from the generating units and the centrally-located computer. The architecture for generation control that we propose in this paper does not rely on such a centrally-located computer. Instead, the implementation of the control functions is distributed and relies on low-complexity iterative algorithms that only use local measurements and certain information acquired through exchange of information with neighboring generating units. We provide analytical and experimental results that verify the effectiveness of the proposed architecture for generation control in smallfootprint power systems, and illustrate the performance of the aforementioned distributed algorithms under a variety of scenarios. S. T. Cady and A. D. Domı́nguez-Garcı́a are with the ECE Department at the University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. E-mail: {scady2, aledan}@ILLINOIS.EDU. C. N. Hadjicostis is with the ECE Department at the University of Cyprus, Nicosia, Cyprus, and also with the ECE Department at the University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. E-mail: chadjic@UCY.AC.CY. The work of S. T. Cady and A. D. Domı́nguez-Garcı́a was supported in part by the National Science Foundation (NSF) under grant ECCSCPS-1135598. The work of C. N. Hadjicostis was supported in part by the European Commission (EC) Seventh Framework Programme (FP7/2007-2013), under grant agreements INFSO-ICT-223844 and PIRG02-GA-2007-224877. Any opinions, findings, and conclusions or recommendations expressed here are those of the authors and do not necessarily reflect the views of NSF or EC. COORDINATED SCIENCE LABORATORY TECHNICAL REPORT UILU-ENG-13-2206 2
Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects

Young Ho Lee,Gwan Gyu Song

DOI: https://doi.org/10.1177/09612033241257134

IF: 2.858

2024-05-22

Lupus

Abstract:Lupus, Ahead of Print. ObjectivesOur objective was to assess the overall and cause-specific standardized mortality ratios (SMRs) among patients diagnosed with systemic lupus erythematosus (SLE).MethodsAn exhaustive systematic review was undertaken, encompassing studies that scrutinized SMRs, both overall and for specific causes, in patients diagnosed with SLE compared to the general populace. The databases of PUBMED, EMBASE, and Cochrane were meticulously searched to collate relevant literature. Following this comprehensive search, a meta-analysis was executed to methodically assess all-cause, sex-specific, ethnicity-specific, and cause-specific SMRs in individuals with SLE.ResultsThe inclusion criteria were met by 29 studies encompassing 72,342 patients with SLE and documenting 7352 deaths. The meta-analysis disclosed a pronounced 2.87-fold elevation in the SMR for all-cause mortality in SLE patients relative to the general population (SMR, 2.866; 95% confidence interval [CI], 2.490–3.242; p < .001). Region-specific assessments showed variable all-cause SMRs, with Europe reporting 2.607 (95% CI, 1.939–3.275; p < .001), Asia revealing 3.043 (95% CI, 2.082–4.004; p < .001), and particularly high SMRs noted in North America and Oceania. Gender-focused analyses presented a pooled SMR of 3.261 (95% CI, 2.674–3.848; p < .001) for females, and 2.747 (95% CI, 2.190–3.304; p < .001) for males. Evaluations specific to cause of death illustrated notably elevated SMRs for renal disease (SMR, 4.486; 95% CI, 3.024–5.948; p < .001), infections (SMR, 4.946; 95% CI, 4.253–5.639; p < .001), cardiovascular diseases (CVD) (SMR, 2.931; 95% CI, 1.802–4.061; p < .001), cerebrovascular accidents (CVA) (SMR, 1.588; 95% CI, 0.647–2.528; p = .001), and cancer (SMR, 1.698; 95% CI, 0.871–2.525; p < .001).ConclusionsThis meta-analysis underscores a significant 2.87-fold elevation in the SMR among patients with SLE compared to the general population, transcending differences in sex or geographical regions. Moreover, an appreciable increase in mortality due to specific causes, including renal disease, infection, CVD, CVA, malignancy, and neuropsychiatric SLE, accentuates the imperative for targeted interventions to mitigate these elevated risks in SLE patients.

rheumatology
A Poultry‐Processing Model for Quantitative Microbiological Risk Assessment

M. Nauta,Ine van der Fels-Klerx,A. Havelaar

DOI: https://doi.org/10.1111/j.0272-4332.2005.00569.x

2005-02-01

Risk Analysis

Abstract:A poultry‐processing model for a quantitative microbiological risk assessment (QMRA) of campylobacter is presented, which can also be applied to other QMRAs involving poultry processing. The same basic model is applied in each consecutive stage of industrial processing. It describes the effects of inactivation and removal of the bacteria, and the dynamics of cross‐contamination in terms of the transfer of campylobacter from the intestines to the carcass surface and the environment, from the carcasses to the environment, and from the environment to the carcasses. From the model it can be derived that, in general, the effect of inactivation and removal is dominant for those carcasses with high initial bacterial loads, and cross‐contamination is dominant for those with low initial levels. In other QMRA poultry‐processing models, the input‐output relationship between the numbers of bacteria on the carcasses is usually assumed to be linear on a logarithmic scale. By including some basic mechanistics, it is shown that this may not be realistic. As nonlinear behavior may affect the predicted effects of risk mitigations; this finding is relevant for risk management. Good knowledge of the variability of bacterial loads on poultry entering the process is important. The common practice in microbiology to only present geometric mean of bacterial counts is insufficient: arithmetic mean are more suitable, in particular, to describe the effect of cross‐contamination. The effects of logistic slaughter (scheduled processing) as a risk mitigation strategy are predicted to be small. Some additional complications in applying microbiological data obtained in processing plants are discussed.
Comparison of Contributors to Mortality Differences in SLE Patients with Different Initial Disease Activity: A Larger Multicenter Cohort Study

Ziyi Jin,Zheng Chen,Wenyou Pan,Lin Liu,Min Wu,Huaixia Hu,Xiang Ding,Hua Wei,Yaohong Zou,Xian Qian,Meimei Wang,Jian Wu,Juan Tao,Jun Tan,Zhanyun Da,Miaojia Zhang,Jing Li,Xuebing Feng,Lingyun Sun

DOI: https://doi.org/10.3390/jcm12031061

IF: 3.9

2023-01-01

Journal of Clinical Medicine

Abstract:To explore the etiology of risk factors and quantify the mortality differences in systemic lupus erythematosus (SLE) patients with different initial disease activity. The Jiangsu Lupus database was established by collecting medical records from first-hospitalized SLE patients during 1999–2009 from 26 centers in Jiangsu province, China, and their survival status every five years. The initial SLEDAI scores [high (>12) vs. low–moderate (≤12)] differences in mortality attributable to risk factors were quantified using population attributable fraction (PAF), relative attributable risk (RAR) and adjusted relative risk (ARR). Among 2446 SLE patients, 83 and 176 deaths were observed in the low–moderate and high activity groups, with mortality rates of 7.7 and 14.0 per 1000 person years, respectively. Anemia was the leading contributor to mortality, with PAFs of 40.4 and 37.5 in the low–moderate and high activity groups, respectively, and explained 23.2% of the mortality differences with an ARR of 1.66 between the two groups. Cardiopulmonary involvement caused the highest PAFs in the low–moderate (20.5%) and high activity (13.6%) groups, explaining 18.3% of the mortality differences. The combination of anemia and cardiopulmonary involvement had the highest RAR, causing 39.8% of the mortality differences (ARR = 1.52) between the two groups. In addition, hypoalbuminemia and a decrease in the creatinine clearance rate accounted for 20–30% of deaths and explained 10–20% of the mortality differences between the two groups, while antimalarial drug nonuse accounted for about 35% of deaths and explained 3.6% of the mortality differences. Anemia, cardiopulmonary involvement and hypoalbuminemia may cause substantial mortality differences across disease activity states, suggesting additional strategies beyond disease activity assessment to monitor SLE outcomes.
Clinical Features of Systemic Lupus Erythematosus with Pulmonary Pleural Lesion in Children

Yan-feng Zhao,Mei-ping Lu,Zhi-min Chen

DOI: https://doi.org/10.3785/j.issn.1008-9292.2012.03.016

2012-01-01

Abstract:OBJECTIVE:To investigate the clinical features of systemic lupus erythematosus (SLE) with pulmonary pleural lesion in children. METHODS:One hundred and thirty three child patients with SLE admitted from 2001 to 2010 were enrolled in the study. The clinical data, chest X-ray findings and laboratory examination were retrospectively reviewed. Cases with infectious pulmonary pleural lesion were excluded. RESULTS:According to chest X-ray findings pleural pulmonary lesions were involved in 45 out of 133 cases with SLE (33.83 %); however, only 30 cases (66.67 %) had positive respiratory manifestations. Respiratory features included cough and/or sputum (55.56 %), dyspnea and chest pain (15.56 % and 11.11 %), and only 28.89 % case with pleural pulmonary lesions had rales. Chest X-ray findings included pleural effusion/pleurisy (32 cases, 71.11%), bronchial pneumonia (21 cases, 46.67%) or interstitial pulmonary disease (13 cases, 28.89%). Compared to children without pulmonary pleural lesion, children with pulmonary pleural lesion had higher incidence of leukopenia, lower C₃ or antibody dsDNA (+) (all P<0.05). There was no difference in abnormality of erythrocyte sedimentation rate (ESR), CRP, IgG,IgA,IgM, thrombocytopenia, antibody ANA(+), anti-SSA(+), anti-SSB(+) or anti-Sm(+) between children with or without pulmonary pleural lesion (P>0.05). CONCLUSION:High incidence of pulmonary pleura lesions are present in children with SLE, however, clinical manifestations are lack of specificity or even no respiratory manifestation. Chest X-ray or HRCT scan are necessary in all cases with SLE. Children with leukopenia, lower C₃ or antibody dsDNA (+) are more likely to have pulmonary pleural lesion.
Associations of Clinical Features and Prognosis with Age at Disease Onset in Patients with Systemic Lupus Erythematosus.

X. Feng,Y. Zou,W. Pan,X. Wang,M. Wu,M. Zhang,J. Tao,Y. Zhang,K. Tan,J. Li,Z. Chen,X. Ding,X. Qian,Z. Da,M. Wang,L. Sun

DOI: https://doi.org/10.1177/0961203313513508

IF: 2.858

2013-01-01

Lupus

Abstract:The objective of this study is to evaluate the association of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus (SLE) in a large, multicenter Chinese cohort. Medical records of 1898 SLE inpatients from 15 hospitals were reviewed and classified into three groups according to their ages at disease presentation. Categorical data were analyzed by chi-square test and potentially associated factors were tested by multinomial logistic regression. Among the patients studied, 259 (13.6%) were juvenile onset (≤18 years), 1444 (76.1%) were early onset (>18 and ≤45 years) and 195 (10.3%) were late onset (>45 years). Whenever manifestations occurred, most patients (>80%) were diagnosed within two years. Juvenile-onset patients were more likely to be untreated before admission (p < 0.001) and have mucocutaneous manifestations (p < 0.001), but musculoskeletal symptoms (p < 0.05) and leukopenia (p < 0.05) were less frequent, while comorbidities were much higher in patients with late-onset SLE (p < 0.001). Neuropsychiatric, cardiopulmonary, renal and gastrointestinal involvement, disease activity index and damage scores were similar among three groups. Anti-Sm antibodies were less prevalent in late-onset patients (p < 0.05) and antimalarial drugs were more often applied to juvenile-onset patients (p < 0.001). As expected, mortality was elevated in the late-onset SLE group (p < 0.05), in which nearly half died of infections, which was much higher than those in the other two groups (p < 0.001). Logistic regression confirmed that patients with juvenile- and early-onset disease were associated with high incidence of being untreated prior to admission, and with low incidence of comorbidities as well as deaths caused by infection compared to patients with late-onset lupus. Interestingly, our data showed that more patients with late-onset disease had a SLEDAI score change of >7 at discharge. In conclusion, age at onset has an impact on SLE disease status, and infection is the main cause of death in those with late-onset lupus. Considering that the late-onset patients had simultaneously easily controllable diseases and high incidence of comorbidities, a different treatment strategy from younger patients should be considered.
Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus

S Zhang,J Su,X Li,X Zhang,S Liu,L Wu,L Ma,L Bi,X Zuo,L Sun,C Huang,J Zhao,M Li,X Zeng,

DOI: https://doi.org/10.1177/0961203315585813

IF: 2.858

2015-05-13

Lupus

Abstract:Introduction Many studies have shown that differences were observed between male and female lupus patients. Although systemic lupus erythematosus (SLE) affects mostly females (female:male ratio 9:1), male SLE patients show higher mortality due to kidney and neurological disease. Currently there are limited epidemiological data concerning lupus in the Chinese population. As such, the Chinese SLE Treatment and Research group (CSTAR) developed the first online registry of Chinese lupus patients in 2009, and represents a multicenter observational study that attempts to describe and compile the major clinical characteristics of lupus in Chinese patients. Objective To investigate the effect of gender on the phenotypes of Chinese SLE patients. Patients and methods Data for 2104 SLE patients were prospectively collected and included in the CSTAR registry. Patients fulfilled the 1997 American College of Rheumatology (ACR) SLE classification criteria. We conducted a cross-sectional case-control study to analyze patient clinical and laboratory data at onset and at enrollment. SLE disease activity scores (SLEDAI) were also measured at enrollment. Results This study included 1914 women and 190 men. Males and females showed no differences in mean ages at onset, delay of diagnosis and disease duration. Males presented more frequently with fever ( p = 0.003), while musculoskeletal involvement ( p = 0.001) and cytopenia ( p = 0.017) was more common in females as the initial manifestation at onset of SLE. For manifestations at enrollment, males presented more frequently with fever ( p = 0.005), renal disease ( p = 0.019), vasculitis ( p = 0.032) and neuropsychiatric lupus ( p = 0.007). For cumulative manifestations at enrollment, males presented more frequently with discoid rash ( p < 0.001) and neuropsychiatric lupus ( p = 0.036), while less frequently with arthritis ( p = 0.011). However, the laboratory data showed no significant differences between the two groups at enrollment. Males also had higher SLEDAI scores at enrollment ( p = 0.002). Conclusions Renal disease, vasculitis and neuropsychiatric lupus are more common in male SLE patients with higher SLEDAI scores compared to female SLE patients in China.

rheumatology
[Clinical Manifestations of Patients with Systemic Lupus Erythematosus and Coronary Artery Disease].

Jing Yang,Dong Xu,Zhu-jun Shen,Chong-hui Wang,Shu-yang Zhang,Zhong-jie Fan,Xiao-feng Jin,Yong Zeng,Zhen-yu Liu,Hong-zhi Xie,Quan Fang

DOI: https://doi.org/10.3760/cma.j.issn.0253-3758.2012.05.006

2012-01-01

Abstract:OBJECTIVE:To analyze the clinical characteristics of patients with systemic lupus erythematosus (SLE) and coronary artery disease (CAD).METHODS:Clinical data of 3911 SLE patients were retrospectively analyzed and CAD was diagnosed by coronary angiography in 26 (0.7%) SLE patients (10 stable angina pectoris, 5 unstable angina pectoris, 8 STEMI and 3 non-STEMI). The tradition risk factors, first onset of cardiac events, blood biochemistry index, treatment and activity of SLE, coronary angiographic features were compared with 552 CAD patients without SLE.RESULTS:Compared with CAD patients without SLE, CAD patients with SLE were younger [(50.4 ± 15.2) years vs. (60.6 ± 11.6) years, P < 0.01], the mean number per patient of Framingham tradition risk factors was less (1.11 ± 1.18 vs. 2.50 ± 1.28, P < 0.05). CAD patients with SLE were prone to premature coronary artery disease [76.9% (20/26)], and ACS was the most common manifestation in SLE patients with premature coronary artery disease [65.0% (13/20)], the duration of steroid use was significantly longer [24.00 (3.75, 57.00) months vs. 1.00 (0.00, 2.00) months, P < 0.05] and 24 hours total urine protein [(1.93 ± 1.97) g vs. (0.76 ± 0.75) g, P < 0.05] was significantly higher in the ACS patients with SLE than non-ACS patients with SLE. Coronary stenosis was evidenced in most of the SLE patients with CAD [76.9% (20/26)] and incidence of coronary thrombotic occlusion was significantly higher in SLE patients with CAD than CAD patients without SLE [30.8% (8/26) vs. 11.8% (65/552), P < 0.05].CONCLUSION:The incidence of CAD in SLE patients is low and the major form of CAD in SLE patients is premature coronary artery disease and mostly induced by coronary thrombotic occlusion.

A quick and inexpensive method for immediate pontic fabrication.

Hematogenous dissemination of Hodgkin's disease.

Causes of Death in Hospitalized Patients with Systemic Lupus Erythematosus: a 10-Year Multicenter Nationwide Chinese Cohort

Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China

A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum

Differences In Clinical Features And Laboratory Results Between Adults And Children With Sars-Cov-2 Infection

Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients

Re: "Those who were wrong".

A clinical analysis of male and female patients with systemic lupus erythematosus in child-bearing age

Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study

A comparative study between the disease characteristics in adult-onset and childhood-onset systemic lupus erythematosus in Egyptian patients attending a large university hospital

Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study

Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey

A Distributed Generation Control Architecture for Small-Footprint Power Systems

Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects

A Poultry‐Processing Model for Quantitative Microbiological Risk Assessment

Comparison of Contributors to Mortality Differences in SLE Patients with Different Initial Disease Activity: A Larger Multicenter Cohort Study

Clinical Features of Systemic Lupus Erythematosus with Pulmonary Pleural Lesion in Children

Associations of Clinical Features and Prognosis with Age at Disease Onset in Patients with Systemic Lupus Erythematosus.

Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus

[Clinical Manifestations of Patients with Systemic Lupus Erythematosus and Coronary Artery Disease].